Details for 2016188627

Up to date per 05.04.2026

Actions

Title / Product Name

ORALE FORMULIERUNGEN VON DEFERASIROX

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016188627

EP Publication Number

3124018

E-Number

955717

Language

PCT Number

Publication Date

01.02.2017 A

20.12.2017 B1

Registration Date

20.12.2017

AT Publication Date

15.01.2018

Application Date

06.03.2014

Registration Number

Priorities

08.03.2013

201361774893 P

17.05.2013

201361824435 P

IPC

A61K 9/20 20060101AFI20161129BHEP

Maximum Duration of Protection

06.03.2034

Owner

NOVARTIS AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

GHOSH, Indrajitc/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

ZHANG, Jia-Aic/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

Information about Fees